xolremdi
Generic: mavorixafor
xolremdi: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| X4 Pharmaceuticals, Inc (XFOR) | Approved |
Get deeper analysis on xolremdi
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis